scholarly journals A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment

2022 ◽  
Author(s):  
Swan Lin ◽  
Jason Gong ◽  
George C. Canas ◽  
Peter Winkle ◽  
Kathleen Pelletier ◽  
...  
Keyword(s):  
Renal Impairment ◽  
Phase I ◽  
Phase I Study ◽  
Severe Renal Impairment

scholarly journals A Phase I Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Adults With Severe Renal Impairment and Healthy Matched Control Participants

2019 ◽  
Vol 8 (5) ◽  
pp. 674-681 ◽  
Author(s):  
Ridhi Parasrampuria ◽  
Susan L. Ford ◽  
Yu Lou ◽  
Caifeng Fu ◽  
Kalpana K. Bakshi ◽  
...  
Keyword(s):  
Renal Impairment ◽  
Phase I ◽  
Phase I Study ◽  
Matched Control ◽  
Severe Renal Impairment

scholarly journals Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study

2012 ◽  
pp. 407
Author(s):  
Lieve Vandeplassche ◽  
Smith ◽  
Mannaert ◽  
Verhaeghe ◽  
Kerstens ◽  
...  
Keyword(s):  
Single Dose ◽  
Renal Impairment ◽  
Phase I ◽  
Phase I Study ◽  
Open Label ◽  
Open Label Phase

scholarly journals How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study

2014 ◽  
Vol 77 (3) ◽  
pp. 498-508 ◽  
Author(s):  
Nicolas Isambert ◽  
Jean Pierre Delord ◽  
Jean Marc Tourani ◽  
Pierre Fumoleau ◽  
Alain Ravaud ◽  
...  
Keyword(s):  
Renal Impairment ◽  
Phase I ◽  
Cancer Patients ◽  
Phase I Study

scholarly journals A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairment

2020 ◽  
Vol 8 (4) ◽  
Author(s):  
Karthick Vishwanathan ◽  
Inmaculada Sanchez‐Simon ◽  
Bhumsuk Keam ◽  
Nicolas Penel ◽  
Maria Miguel‐Luken ◽  
...  
Keyword(s):  
Renal Function ◽  
Renal Impairment ◽  
Phase I ◽  
Cancer Patients ◽  
Pharmacokinetic Study ◽  
Normal Renal Function ◽  
Severe Renal Impairment ◽  
Multicenter Phase

scholarly journals Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumors

2012 ◽  
Vol 23 (4) ◽  
pp. 1037-1044 ◽  
Author(s):  
M.D. Galsky ◽  
L.H. Camacho ◽  
E.G. Chiorean ◽  
D. Mulkerin ◽  
D.S. Hong ◽  
...  
Keyword(s):  
Renal Impairment ◽  
Phase I ◽  
Solid Tumors ◽  
Phase I Study
Sign in / Sign up

Export Citation Format

Share Document